Crawford closer to confirmation
This article was originally published in The Rose Sheet
Executive Summary
Acting Commissioner Lester Crawford's nomination to fill the post permanently clears Senate Health Committee by a voice vote June 15. Full Senate vote will be delayed, however, since Sens. Patty Murray (D-Wash.) and Hillary Clinton (D-N.Y.) have placed a hold on the nomination pending a decision by FDA on over-the-counter switch application for Barr's Plan B emergency contraceptive. Sen. Tom Coburn (R-Okla.) has also placed a hold on Crawford's confirmation due to concerns about FDA's relabeling of condoms. Crawford was cleared of certain allegations regarding inappropriate behavior with a subordinate by a June 7 HHS Inspector General report, enabling Health panel vote (1"The Rose Sheet" June 6, 2005, p. 10)...
You may also be interested in...
IG Inquiry Clears Crawford Of Three Personal Conduct Allegations
The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner-nominee Lester Crawford could remove one roadblock in his confirmation process
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.